Joseph Jimenez at the World Economic Forum
http://www.weforum.org/ This year saw the launch of a one-shot gene therapy with a money-back guarantee should the treatment not work. Is the time ripe for a new era of drug pricing based on patient outcome?
- Lloyd Dean, President and Chief Executive Officer, Dignity Health, USA - Omar Ishrak, Chairman and Chief Executive Officer, Medtronic, USA - Joseph Jimenez, Chief Executive Officer, Novartis, Switzerland - Risa Lavizzo-Mourey, Chief Executive Officer and President, Robert Wood Johnson Foundation (RWJF), USA - Steve Rusckowski, Chairman, President and Chief Executive Officer, Quest Diagnostics, USA
Moderated by
- Allison Aubrey, Correspondent, National Public Radio, USARelevantní články
Joseph JimenezJoseph „Joe“ Jimenez je manažer pocházející z USA. Od roku 2010 je CEO ve švýcarském farmaceutickém koncernu Novartis. .. pokračovat ve čtení